BioSpace - Aphton Corporation News, Search Jobs, Events
Aphton Corporation 444 Brickell Avenue Suite 51-507 ... Aphton Corporation (APHT ) Announces Closing of Commercialization and Manufacturing Agreements for ...
http://www.biospace.com/company_profile.aspx?CompanyID=1748...
|
BioPortfolio - Aphton Corporation
Aphton Corporation - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/395-Aphton_Corporat...
|
Aphton Corporation Company Profile - Yahoo! Finance
Capsule info for Aphton Corporation. ... Aphton has halted work on lead candidate Insegia, an anti-gastrin vaccine to combat pancreatic cancer, ...
http://biz.yahoo.com/ic/42/42108.html...
|
Gastrin 17 vaccine--Aphton: Anti-gastrin 17 immunogen, G17DT.
Aphton is developing an anti-gastrin vaccine [Anti-gastrin 17 immunogen, G17DT, Gastrimmune], which neutralises the gastrin 17 hormone and the Gly-G17 ...
http://www.ncbi.nlm.nih.gov/pubmed/12749761...
|
BioPortfolio - Aphton Corporation patents
Aphton Corporation patents - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/395-Aphton+Corporat...
|
Receptor BioLogix Inc. Acquires Late-Stage Cancer Drug From Aphton ...
Receptor BioLogix Inc. Acquires Late-Stage Cancer Drug From Aphton Corporation ( APHT) 7/31/2006 ... and related assets, from Philadelphia-based Aphton Corp. ...
http://www.biospace.com/news_story.aspx?NewsEntityId=25806...
|
BioPortfolio - BioPortfolio - Aphton Corporation
BioPortfolio - Aphton Corporation - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/linkout/395/www.aph...
|
BioWorld Today
Aphton's Insegia Misses In Pancreatic Cancer Phase III ... The fall in stock price might affect Aphton's acquisition of Vienna, Austria-based Igeneon AG, ...
http://www.bioworld.com/servlet/com.accumedia.web.Dispatcher...
|
BioPortfolio - Aphton Corporation - Profile
View the current Aphton Corporation Page on BioPortfolio.com ... Aphton acquired late-stage products, IGN101, a cancer vaccine designed to induce an immune ...
http://www.bioportfolio.com/biocorporate/18569-Aphton+Corpor...
|
{3} And {4}'s Joint Venture {2} Announce Commercialization And ...
Igeneon is a wholly-owned subsidiary of Aphton Corporation ... For more information about Aphton or its programs please visit Aphton's website at ...
http://www.biospace.com/news_story.aspx?NewsEntityId=2068352...
|
